Looking Into Vertex Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Vertex Pharmaceuticals' short percent of float has risen 6.6% since its last report, with 2.92 million shares sold short, which is 1.13% of all regular shares available for trading. It would take traders 3.92 days to cover their short positions on average. The company's short interest is less than its peer group average of 3.60%.
September 26, 2023 | 7:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Vertex Pharmaceuticals' short interest has increased, indicating a bearish market sentiment. However, its short interest is less than its peer group average.
An increase in short interest indicates that more investors are betting that the stock price will fall. However, the fact that Vertex's short interest is less than its peer group average could suggest that it is less bearish compared to its peers.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100